Skip to main content

What the FDA labels say about taking them together

Phenytoin and vinblastine

Vinblastine's FDA label of April 15, 2025 names phenytoin in its drug interactions section; the phenytoin labels PlainMeds reads (2) do not name vinblastine. The vinblastine label: “Drug Interactions The simultaneous oral or intravenous administration of phenytoin and antineoplastic chemotherapy combinations that included vinblastine sulfate has been reported to have reduced blood levels of the …”

Check it at the source: the phenytoin FDA label on DailyMed (effective October 15, 2024, Mylan Pharmaceuticals Inc.); the vinblastine FDA label on DailyMed (effective April 15, 2025, Fresenius Kabi USA, LLC).

What does the phenytoin label say about vinblastine?

Phenytoin's label (effective October 15, 2024) and its 1 other brand-application label do not name vinblastine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenytek), Mylan Pharmaceuticals Inc., effective October 15, 2024 (SPL set 0f94c791-8b07-4b41-927e-c9f28bec5f60), via openFDA; the full label on DailyMed

What does the vinblastine label say about phenytoin?

Vinblastine label, drug interactions

Drug Interactions The simultaneous oral or intravenous administration of phenytoin and antineoplastic chemotherapy combinations that included vinblastine sulfate has been reported to have reduced blood levels of the anticonvulsant and to have increased seizure activity.

Source: FDA drug label (Vinblastine Sulfate), Fresenius Kabi USA, LLC, effective April 15, 2025 (SPL set f073b58e-56d6-4c8d-a2ce-b37719402d77), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

29Phenytoin generic labelers
1Vinblastine generic labelers
PhenytoinVinblastine
Labeled forSeizures and epilepsyLeukemia, lymphoma and myeloma
Boxed warningNoYes
Pharmacy cost (NADAC)$0.145 per capsule 100 mg capsulen/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?